Rebecca Ann Harvey

Title: The Innovative Contributions of Rebecca Ann Harvey

Introduction

Rebecca Ann Harvey is a notable inventor based in Lancashire, GB. She has made significant contributions to the field of pharmaceuticals, holding a total of four patents. Her work primarily focuses on the development of compounds that have potential applications in treating hyperproliferative disorders.

Latest Patents

Among her latest patents are the "Substituted Macrocyclic Indole Derivatives" and "Macrocyclic Chlorine Substituted Indole Derivatives." The first patent relates to substituted macrocyclic indole derivatives of a specific general formula. It includes methods for preparing these compounds, intermediate compounds useful for their preparation, and pharmaceutical compositions that incorporate these compounds. The second patent similarly addresses macrocyclic indole derivatives, detailing their preparation methods and potential uses in pharmaceutical compositions for treating diseases, particularly hyperproliferative disorders.

Career Highlights

Rebecca has worked with prominent companies such as Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. Her experience in these organizations has allowed her to develop her expertise in pharmaceutical innovations and contribute to significant advancements in the field.

Collaborations

Rebecca has collaborated with notable coworkers, including Kai Thede and Anne Mengel. These partnerships have likely enriched her research and development efforts, fostering a collaborative environment for innovation.

Conclusion

Rebecca Ann Harvey's contributions to the field of pharmaceuticals through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in treatments for hyperproliferative disorders.